Healthy women needed to test camizestrant drug interactions
NCT ID NCT06547164
First seen Sep 30, 2025 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This study looks at how a new drug called camizestrant affects the breakdown of other drugs in the body, and vice versa. It involves 40 healthy postmenopausal women who will take camizestrant along with midazolam or carbamazepine. The goal is to understand drug interactions, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Harrow, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.